ANI Pharmaceuticals, Inc. (ANIP)

NGM – Real Time Price. Currency in USD

79.50

+0.79 (1.00%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

883M

614M

487M

316M

Cost of goods sold

-433M

-318M

-241M

-196M

Gross Profit

451M

296M

246M

121M

Operating expenses (excl. COGS)

-369M

-294M

-196M

-146M

Operating Income

81M

50M

-26M

Non-operating income, total

15M

-24M

-30M

-37M

Pretax income

96M

-22M

20M

-63M

Equity in earnings

Taxes

-17M

-1M

15M

Non-controlling/minority interest

After tax other income/expense

-7M

Net income before discontinued operations

71M

-19M

19M

-48M

ANI Pharmaceuticals, Inc. (ANIP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ANI Pharmaceuticals, Inc. (ANIP)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

ANI Pharmaceuticals, Inc. (ANIP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ANI Pharmaceuticals, Inc. (ANIP)

Income Statement (Annual)

Income Statement (Annual)